Literature DB >> 8585884

Experience with side effects and health risks associated with Norplant implant use in adolescents.

S L Rosenthal1, F M Biro, L M Kollar, P J Hillard, J L Rauh.   

Abstract

Levonorgestrel implants (Norplant) have been recommended as a contraceptive method for teenage women. Our experience suggests that the use of Norplant implants in adolescents is associated with bleeding irregularities and modest weight gain. There is no effect on condom use or STD acquisition. Despite the bleeding irregularities, we documented high continuation rates, suggesting that with appropriate pre-insertion counseling, Norplant implants can be a successful contraceptive method for adolescent women.

Entities:  

Keywords:  Adolescents; Adolescents, Female; Age Factors; Americas; Clinical Research; Contraception; Contraception Continuation; Contraceptive Agents, Female--side effects; Contraceptive Agents, Progestin--side effects; Contraceptive Agents--side effects; Contraceptive Implants--side effects; Contraceptive Methods--side effects; Contraceptive Usage; Demographic Factors; Developed Countries; Family Planning; Levonorgestrel--side effects; North America; Northern America; Population; Population Characteristics; Research Methodology; United States; Youth

Mesh:

Substances:

Year:  1995        PMID: 8585884     DOI: 10.1016/0010-7824(95)00212-s

Source DB:  PubMed          Journal:  Contraception        ISSN: 0010-7824            Impact factor:   3.375


  3 in total

Review 1.  Levonorgestrel subdermal implants. Contraception on trial.

Authors:  M L Frank; C DiMaria
Journal:  Drug Saf       Date:  1997-12       Impact factor: 5.606

Review 2.  Research on adolescents and microbicides: a review.

Authors:  Amanda E Tanner; Mary B Short; Gregory D Zimet; Susan L Rosenthal
Journal:  J Pediatr Adolesc Gynecol       Date:  2009-07-17       Impact factor: 1.814

Review 3.  Levonorgestrel subdermal implants. A review of contraceptive efficacy and acceptability.

Authors:  A J Coukell; J A Balfour
Journal:  Drugs       Date:  1998-06       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.